The unique environment of space (including microgravity) exposes long-duration spaceflight (LDSF) participants to numerous physiologic challenges [1, 2]. In preparation for future crewed missions to the Moon and Mars, the National Aeronautics and Space Administration (NASA) Human Research Program has compiled a list of health risks associated with spaceflight [1]. One such risk, labelled as “red” for the highest priority, is a collection of neurologic and ophthalmic findings termed spaceflight associated neuro-ocular syndrome (SANS) [1,2,3]. The clinical and imaging findings of SANS include optic disc oedema, globe flattening, retinal nerve fibre layer thickening, chorioretinal folds, hyperopic shifts, and cotton-wool spots [4,5,6]. About 70% of all crewmembers who have participated in LDSF have demonstrated one or more of these neuro-ocular signs [6]. While the precise mechanism of SANS remains ill-defined, a major contributing factor is thought to be the cephalad fluid shift and subsequent venous congestion that occurs upon exposure to microgravity during LDSF [4,5,6,7].
Despite this redistribution of fluid towards the head, chronic elevation of intra-ocular pressure (IOP) has not been observed in astronauts on long-duration space flights [4,5,6]. A transient spike in IOP occurs as astronauts enter microgravity, followed by a decrease over the period of days to clinically normal levels [5, 6, 8]. This normalization of IOP during spaceflight occurs despite a sustained cephalad venous fluid shift [9]. A proposed explanation is a compensatory decrease in aqueous volume [5].
The conventional aqueous outflow pathway accounts for approximately 75–90% of aqueous outflow, in which aqueous humour flows through the trabecular meshwork (TM) into Schlemm’s canal (SC) before exiting the eye via episcleral veins [10]. According to the simplified Goldmann equation, factors affecting IOP include aqueous humour production, facility of trabecular outflow, and episcleral venous pressure [11]. As histologic studies indicate a strong correlation between outflow capacity and dimensions of outflow pathway sites, alterations in the morphology of the conventional outflow pathway could be a major contributor to the normalization of IOP in microgravity [12].
Advancements in ocular imaging allow for visualization of SC and the TM in vivo. Ultrasound biomicroscopy (UBM) enables imaging of anterior segment structures in high resolution using a higher frequency transducer than that of traditional ophthalmic ultrasound (a 50–100 MHz vs 10 MHz). With UBM, significant decreases in both the coronal diameter of SC and thickness of the TM in patients with primary open angle glaucoma (POAG) have been demonstrated [13]. Anterior segment optical coherence tomography (AS-OCT) is another newer modality that can produce cross-sectional images at an even higher resolution than UBM [14]. With these modalities, new avenues of investigation into physiologic changes in anterior segment structures have become available.
AS-OCT has been used to evaluate the therapeutic effect of medical and procedural treatments for terrestrial POAG. An increase in SC surface area by >90% was observed after treatment with a topical prostaglandin prodrug (travoprost), a medication approved to lower IOP in POAG, with maintenance of SC surface area seen up to 84 h following eye drop instillation [15]. In addition, laser treatments (e.g., selective laser trabeculoplasty) target expansion of SC cross-sectional area (CSA) and can decrease IOP from increased outflow facility [16, 17].
Physiologic alteration of the aqueous outflow apparatus morphology has been observed after exercise and during forced Valsalva manoeuvre. After aerobic exercise, increased TM thickness and SC CSA have been imaged with AS-OCT [18]. This alteration in morphology, and its consequent increase in trabecular outflow facility is presumed to be a response to the IOP elevation induced by aerobic exercise [19]. An additional example of a physiologic compensation for increased IOP is the increase in SC CSA observed after subjects performed a Valsalva manoeuvre, a forceful exhalation against a closed airway that is associated with an elevation in IOP [20].
A longitudinal investigation of changes in the aqueous outflow pathway during microgravity may be useful in studying SANS during LDSF. Currently, head down tilt (HDT) bed rest (HDTBR) is a terrestrial analogue to microgravity. Supine subjects in bed are tilted down to produce a cephalad fluid shift [21]. Individuals following HDT have demonstrated a similar pattern of IOP normalization over time to that observed in astronauts [22]. Using AS-OCT, Chen et al. documented a decrease in SC CSA in individuals subject to brief HDT [23]. After 15 min of 20° HDT, IOP increased significantly from 14 to 17 mm Hg, and SC CSA decreased from a sitting value of 13449 µm2 to a posttest value of 9576 µm2. These changes in SC CSA may reflect what occurs as astronauts enter space, which would align with the observed transient spike in IOP. Both validation of these findings in space and longer duration HDT studies on Earth would contribute to our understanding of IOP regulation.
We propose to use AS-OCT and UBM to study the anterior segment in HDTBR and SANS. Because these modalities are noninvasive and produce high resolution cross-sections of the anterior segment, they would be suited for longitudinal assessment of structural changes to SC and the TM. Previous studies have indicated that changes in the dimensions of SC and the TM are associated with changes in IOP (Table 1). Over a period of days, an increase in the dimensions of SC and the thickness of the TM may be contributing to increased aqueous outflow by increasing trabecular outflow facility. An increase in outflow could explain the observed normalization of IOP that occurs during long-duration exposure to microgravity. Elucidation of this mechanism is also expected to provide novel insights into POAG pathophysiology, a disease with a mysterious aetiology despite being the second leading cause of blindness worldwide.
References
Human Research Roadmap [Internet]. [cited 2023 Nov]. Available from: https://humanresearchroadmap.nasa.gov/.
Patel ZS, Brunstetter TJ, Tarver WJ, Whitmire AM, Zwart SR, Smith SM, et al. Red risks for a journey to the red planet: the highest priority human health risks for a mission to Mars. NPJ Microgravity. 2020;6:1–13.
Lee AG, Mader TH, Gibson CR, Tarver W, Rabiei P, Riascos RF, et al. Spaceflight associated neuro-ocular syndrome (SANS) and the neuro-ophthalmologic effects of microgravity: a review and an update. NPJ Microgravity. 2020;6:7.
Lee AG, Tarver WJ, Mader TH, Gibson CR, Hart SF, Otto CA. Neuro-ophthalmology of space flight. J Neuro-Ophthalmol J North Am Neuro-Ophthalmol Soc. 2016;36:85–91.
Mader TH, Gibson CR, Pass AF, Kramer LA, Lee AG, Fogarty J, et al. Optic disc edema, globe flattening, choroidal folds, and hyperopic shifts observed in astronauts after long-duration space flight. Ophthalmology. 2011;118:2058–69.
Stenger MB, Tarver WJ, Brunstetter T, Gibson CR, Laurie SS, Lee S, et al. Evidence report: risk of spaceflight associated neuro-ocular syndrome (SANS). 2017 https://ntrs.nasa.gov/api/citations/20180000936/downloads/20180000936.pdf.
Ong J, Tarver W, Brunstetter T, Mader TH, Gibson CR, Mason SS, et al. Spaceflight associated neuro-ocular syndrome: proposed pathogenesis, terrestrial analogues, and emerging countermeasures. Br J Ophthalmol. 2023;10:895–900.
Draeger J, Schwartz R, Groenhoff S, Stern C. Self-tonometry under microgravity conditions. Clin Investig. 1993;71:700–3.
Marshall-Goebel K, Laurie SS, Alferova IV, Arbeille P, Auñón-Chancellor SM, Ebert DJ, et al. Assessment of jugular venous blood flow stasis and thrombosis during spaceflight. JAMA Netw Open. 2019;2:e1915011.
Grant WM. Clinical measurements of aqueous outflow. Am J Ophthalmol. 1951;34:1603–5.
Goldmann H. [Minute volume of the aqueous in the anterior chamber of the human eye in normal state and in primary glaucoma]. Ophthalmol J Int Ophtalmol Int J Ophthalmol Z Augenheilkd. 1950;120:19–21.
Allingham RR, de Kater AW, Ethier CR. Schlemm’s canal and primary open angle glaucoma: correlation between Schlemm’s canal dimensions and outflow facility. Exp Eye Res. 1996;62:101–9.
Yan X, Li M, Chen Z, Zhu Y, Song Y, Zhang H. Schlemm’s canal and trabecular meshwork in eyes with primary open angle glaucoma: a comparative study using high-frequency ultrasound biomicroscopy. PLoS ONE. 2016;11:e0145824.
Kumar RS, Anegondi N, Chandapura RS, Sudhakaran S, Kadambi SV, Rao HL, et al. Discriminant function of optical coherence tomography angiography to determine disease severity in glaucoma. Invest Ophthalmol Vis Sci. 2016;57:6079–88.
Chen J, Huang H, Zhang S, Chen X, Sun X. Expansion of Schlemm’s canal by travoprost in healthy subjects determined by Fourier-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2013;54:1127–34.
Skaat A, Rosman MS, Chien JL, Ghassibi MP, Liebmann JM, Ritch R, et al. Microarchitecture of schlemm canal before and after selective laser trabeculoplasty in enhanced depth imaging optical coherence tomography. J Glaucoma. 2017;26:361–6.
Gong H, Francis A. Schlemm’s canal and collector channels as therapeutic targets. In: Innovations in Glaucoma Surgery. New York: Springer; 2014. 3–25.
Yuan Y, Lin TPH, Gao K, Zhou R, Radke NV, Lam DSC, et al. Aerobic exercise reduces intraocular pressure and expands Schlemm’s canal dimensions in healthy and primary open-angle glaucoma eyes. Indian J Ophthalmol. 2021;69:1127–34.
Yan X, Li M, Song Y, Guo J, Zhao Y, Chen W, et al. Influence of exercise on intraocular pressure, schlemm’s canal, and the trabecular meshwork. Invest Ophthalmol Vis Sci. 2016;57:4733–9.
Sun L, Chen W, Chen Z, Xiang Y, Guo J, Hu T, et al. Dual effect of the Valsalva maneuver on autonomic nervous system activity, intraocular pressure, Schlemm’s canal, and iridocorneal angle morphology. BMC Ophthalmol. 2020;20:5.
Ong J, Lee AG, Moss HE. Head-down tilt bed rest studies as a terrestrial analog for spaceflight associated neuro-ocular syndrome. Front Neurol. 2021;12:648958.
Chiquet C, Custaud MA, Le Traon AP, Millet C, Gharib C, Denis P. Changes in intraocular pressure during prolonged (7-Day) head-down tilt bedrest. J Glaucoma. 2003;12:204.
Chen W, Chen ZQ, Xiang Y, Deng CH, Zhang H, Wang JM. Analogs of microgravity: the function of Schlemm’s canal, intraocular pressure and autonomic nervous during the head-down tilt test in healthy subjects. Int J Ophthalmol. 2021;14:1419–23.
Hong J, Xu J, Wei A, Wen W, Chen J, Yu X, et al. Spectral-domain optical coherence tomographic assessment of Schlemm’s canal in Chinese subjects with primary open-angle glaucoma. Ophthalmology. 2013;120:709–15.
Tandon A, Watson C, Ayyala R. Ultrasound biomicroscopy measurement of Schlemm’s canal in pediatric patients with and without glaucoma. J AAPOS Publ Am Assoc Pediatr Ophthalmol Strabismus. 2017;21:234–7.
Funding
NASA Grant [80NSSC20K183]: A Non-intrusive Ocular Monitoring Framework to Model Ocular Structure and Functional Changes due to Long-term Spaceflight.
Author information
Authors and Affiliations
Contributions
BS and JO participated in conceptualization and writing of the publication, DO, CMK, EW, PS, NZ, AT, GV, and AGL participated in review and intellectual support for the creation of the publication.
Corresponding author
Ethics declarations
Competing interests
Andrew G. Lee, is a consultant for the National Aeronautics and Space Administration (NASA).
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Soares, B., Ong, J., Osteicoechea, D. et al. A potential compensatory mechanism for spaceflight associated neuro-ocular changes from microgravity: current understanding and future directions. Eye (2024). https://doi.org/10.1038/s41433-024-02952-2
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41433-024-02952-2